Anne Altmeyer
Directeur/Membre du Conseil chez CORBUS PHARMACEUTICALS HOLDINGS, INC.
Fortune : 119 112 $ au 31/05/2024
Postes actifs de Anne Altmeyer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Directeur/Membre du Conseil | 20/09/2022 | - |
| Independent Dir/Board Member | 20/09/2022 | - | |
TigaTx, Inc.
 TigaTx, Inc. BiotechnologyHealth Technology TigaTx, Inc. is a biotechnology company that focuses on developing first-in-class, engineered IGA as neutrophil engagers to fight cancer. The company is based in Boston, MA. TigaTx is backed by excellent investors and has an accomplished scientific advisory board. It was founded by Jeanette Leusen and the CEO is Anne Altmeyer. | Directeur/Membre du Conseil | 01/01/2021 | - |
| Directeur Général | 01/01/2021 | - |
Historique de carrière de Anne Altmeyer
Anciens postes connus de Anne Altmeyer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SIGILON THERAPEUTICS, INC. | Corporate Officer/Principal | 01/07/2019 | 01/01/2021 |
| ADICET BIO, INC. | Corporate Officer/Principal | 01/01/2016 | 01/01/2019 |
| BAXALTA INC | Corporate Officer/Principal | 01/01/2015 | 01/01/2016 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2004 | 01/08/2015 |
Formation de Anne Altmeyer
| University of Strasbourg | Doctorate Degree |
| Rutgers University-New Brunswick | Masters Business Admin |
| University of Medicine & Dentistry of New Jersey | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
| France | 2 |
| 2 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| ADICET BIO, INC. | Health Technology |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
TigaTx, Inc.
TigaTx, Inc. BiotechnologyHealth Technology TigaTx, Inc. is a biotechnology company that focuses on developing first-in-class, engineered IGA as neutrophil engagers to fight cancer. The company is based in Boston, MA. TigaTx is backed by excellent investors and has an accomplished scientific advisory board. It was founded by Jeanette Leusen and the CEO is Anne Altmeyer. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
- Bourse
- Insiders
- Anne Altmeyer
- Expérience
